Trials / Completed
CompletedNCT07009769
AI-Driven Precision Diagnostic System for Lung Cancer Based on Liquid Biopsy
Retrospective Clinical Study for Developing an AI-Driven Precision Diagnostic System for Lung Cancer Based on Liquid Biopsy
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 865 (actual)
- Sponsor
- Korea University Guro Hospital · Academic / Other
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Accepted
Summary
The investigators aim to develop an AI-powered precision medicine system based on liquid biopsy that can comprehensively provide lung cancer patients with information on disease stage, histologic subtype, and presence of genetic mutations.
Conditions
Timeline
- Start date
- 2024-10-16
- Primary completion
- 2024-12-31
- Completion
- 2025-05-01
- First posted
- 2025-06-08
- Last updated
- 2025-06-08
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT07009769. Inclusion in this directory is not an endorsement.